We have previously shown that the HSP90 inhibitor AUY922 kills colon cancer cells through apoptosis and that wild-type KRAS colon cancer cells are more resistant to apoptosis induced by AUY922 compared with those carrying active mutations in KRAS [29]. The gene discussed is KRAS; the disease is colonic neoplasm.